Literature DB >> 18838454

Diagnosis and treatment of dementia: 4. Approach to management of mild to moderate dementia.

David B Hogan1, Peter Bailey, Sandra Black, Anne Carswell, Howard Chertkow, Barry Clarke, Carole Cohen, John D Fisk, Dorothy Forbes, Malcolm Man-Son-Hing, Krista Lanctôt, Debra Morgan, Lilian Thorpe.   

Abstract

BACKGROUND: The management of mild to moderate dementia presents complex and evolving challenges. Practising physicians are often uncertain about the appropriate approaches to issues such as the disclosure of the diagnosis, driving and caregiver support. In this article, we provide practical guidance on management based on recommendations from the Third Canadian Consensus Conference on the Diagnosis and Treatment of Dementia.
METHODS: We developed evidence-based guidelines using systematic literature searches, with specific criteria for the selection and quality assessment of articles, and a clear and transparent decision-making process. We selected articles published from January 1996 to December 2005 that dealt with the management of mild to moderate stages of Alzheimer disease and other forms of dementia. Recommendations based on the literature review were drafted and voted on. Consensus required 80% or more agreement by participants. Subsequent to the conference, we searched for additional articles published from January 2006 to April 2008 using the same major keywords and secondary search terms. We graded the strength of evidence using the criteria of the Canadian Task Force on Preventive Health Care.
RESULTS: We identified 1615 articles, of which 954 were selected for further study. From a synthesis of the evidence in these studies, we made 48 recommendations for the management of mild to moderate dementia (28) and dementia with a cerebrovascular component (8) as well as recommendations for addressing ethical issues (e.g., disclosure of the diagnosis) (12). The updated literature review did not change these recommendations. In brief, patients and their families should be informed of the diagnosis. Although the specifics of managing comorbid conditions might require modification, standards of care and treatment targets would not change because of a mild dementia. The use of medications with anticholinergic effects should be minimized. There should be proactive planning for driving cessation, since this will be required at some point in the course of progressive dementia. The patient's ability to drive should be determined primarily on the basis of his or her functional abilities. An important aspect of care is supporting the patient's primary caregiver.
INTERPRETATION: Much has been learned about the care of patients with mild to moderate dementia and the support of their primary caregivers. There is a pressing need for the development, and dissemination, of collaborative systems of care.

Entities:  

Mesh:

Year:  2008        PMID: 18838454      PMCID: PMC2553866          DOI: 10.1503/cmaj.070803

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  35 in total

1.  Delirium risk factors in elderly hospitalized patients.

Authors:  M Elie; M G Cole; F J Primeau; F Bellavance
Journal:  J Gen Intern Med       Date:  1998-03       Impact factor: 5.128

2.  Identification of medications that cause cognitive impairment in older people: the case of oxybutynin chloride.

Authors:  I R Katz; L P Sands; W Bilker; S DiFilippo; A Boyce; K D'Angelo
Journal:  J Am Geriatr Soc       Date:  1998-01       Impact factor: 5.562

3.  Disclosure of the diagnosis of dementia.

Authors:  John D Fisk; B Lynn Beattie; Martha Donnelly; Anna Byszewski; Frank J Molnar
Journal:  Alzheimers Dement       Date:  2007-09-19       Impact factor: 21.566

4.  Chronic exposure to anticholinergic medications adversely affects the course of Alzheimer disease.

Authors:  Ching-ju Lu; Larry E Tune
Journal:  Am J Geriatr Psychiatry       Date:  2003 Jul-Aug       Impact factor: 4.105

5.  Practice constraints, behavioral problems, and dementia care: primary care physicians' perspectives.

Authors:  Ladson Hinton; Carol E Franz; Geetha Reddy; Yvette Flores; Richard L Kravitz; Judith C Barker
Journal:  J Gen Intern Med       Date:  2007-09-07       Impact factor: 5.128

6.  Coping by the carers of dementia sufferers.

Authors:  K Saad; J Hartman; C Ballard; M Kurian; C Graham; G Wilcock
Journal:  Age Ageing       Date:  1995-11       Impact factor: 10.668

Review 7.  Diagnosis and treatment of dementia: 2. Diagnosis.

Authors:  Howard H Feldman; Claudia Jacova; Alain Robillard; Angeles Garcia; Tiffany Chow; Michael Borrie; Hyman M Schipper; Mervin Blair; Andrew Kertesz; Howard Chertkow
Journal:  CMAJ       Date:  2008-03-25       Impact factor: 8.262

8.  The anticholinergic risk scale and anticholinergic adverse effects in older persons.

Authors:  James L Rudolph; Marci J Salow; Michael C Angelini; Regina E McGlinchey
Journal:  Arch Intern Med       Date:  2008-03-10

9.  Reaction to a dementia diagnosis in individuals with Alzheimer's disease and mild cognitive impairment.

Authors:  Brian D Carpenter; Chengjie Xiong; Emily K Porensky; Monica M Lee; Patrick J Brown; Mary Coats; David Johnson; John C Morris
Journal:  J Am Geriatr Soc       Date:  2008-01-05       Impact factor: 5.562

10.  Diagnosis and treatment of dementia: introduction. Introducing a series based on the Third Canadian Consensus Conference on the Diagnosis and Treatment of Dementia.

Authors:  Howard Chertkow
Journal:  CMAJ       Date:  2008-01-29       Impact factor: 8.262

View more
  27 in total

Review 1.  How applicable are clinical practice guidelines to elderly patients with comorbidities?

Authors:  Donatus R Mutasingwa; Hong Ge; Ross E G Upshur
Journal:  Can Fam Physician       Date:  2011-07       Impact factor: 3.275

Review 2.  [Driving ability and dementia].

Authors:  Albert Lukas; Thorsten Nikolaus
Journal:  Z Gerontol Geriatr       Date:  2009-06-28       Impact factor: 1.281

3.  Curing and caring: the work of primary care physicians with dementia patients.

Authors:  Ester Carolina Apesoa-Varano; Judith C Barker; Ladson Hinton
Journal:  Qual Health Res       Date:  2011-06-17

Review 4.  Long-term efficacy and toxicity of cholinesterase inhibitors in the treatment of Alzheimer disease.

Authors:  David B Hogan
Journal:  Can J Psychiatry       Date:  2014-12       Impact factor: 4.356

Review 5.  Care of community-dwelling older adults with dementia and their caregivers.

Authors:  Natalie Warrick; Jeanette C Prorok; Dallas Seitz
Journal:  CMAJ       Date:  2018-07-03       Impact factor: 8.262

6.  Resident-Level Predictors of Dementia Pharmacotherapy at Long-Term Care Admission: The Impact of Different Drug Reimbursement Policies in Ontario and Saskatchewan: Prédicteurs de la pharmacothérapie de la démence au niveau des résidents lors de l'hospitalisation dans des soins de longue durée : l'impact de différentes politiques de remboursement des médicaments en Ontario et en Saskatchewan.

Authors:  Laura C Maclagan; Susan E Bronskill; Michael A Campitelli; Shenzhen Yao; Christoffer Dharma; David B Hogan; Nathan Herrmann; Joseph E Amuah; Colleen J Maxwell
Journal:  Can J Psychiatry       Date:  2020-04-10       Impact factor: 4.356

7.  Integrating Family Caregivers of People With Alzheimer's Disease and Dementias into Clinical Appointments: Identifying Potential Best Practices.

Authors:  Joan M Griffin; Catherine Riffin; Rachel D Havyer; Virginia S Biggar; Meryl Comer; Theresa L Frangiosa; Lauren R Bangerter
Journal:  J Appl Gerontol       Date:  2019-10-11

8.  Sex Differences in the Prevalent Use of Oral Formulations of Cholinesterase Inhibitors in Older Adults with Dementia.

Authors:  Lynn Zhu; Paula A Rochon; Andrea Gruneir; Wei Wu; Vasily Giannakeas; Peter C Austin; Nathan M Stall; Lisa McCarthy; Amanda Alberga; Nathan Herrmann; Sudeep S Gill; Susan E Bronskill
Journal:  Drugs Aging       Date:  2019-09       Impact factor: 3.923

Review 9.  Diagnosis and treatment of dementia: 5. Nonpharmacologic and pharmacologic therapy for mild to moderate dementia.

Authors:  David B Hogan; Peter Bailey; Sandra Black; Anne Carswell; Howard Chertkow; Barry Clarke; Carole Cohen; John D Fisk; Dorothy Forbes; Malcolm Man-Son-Hing; Krista Lanctôt; Debra Morgan; Lilian Thorpe
Journal:  CMAJ       Date:  2008-11-04       Impact factor: 8.262

10.  Development and validation of a brief dementia screening indicator for primary care.

Authors:  Deborah E Barnes; Alexa S Beiser; Anne Lee; Kenneth M Langa; Alain Koyama; Sarah R Preis; John Neuhaus; Ryan J McCammon; Kristine Yaffe; Sudha Seshadri; Mary N Haan; David R Weir
Journal:  Alzheimers Dement       Date:  2014-02-01       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.